GLYALA

Welcome to the Brand page for “GLYALA”, which is offered here for Pharmaceutical preparations, pharmaceutical preparations for use in the treatment and prevention of metabolic disorders, for use in slowing gastric emptying, improving glycemic control, increasing first-phase and second-phase insulin secretion, and in suppression of inappropriate glucagon secretion, and for the treatment and prevention of endocrine conditions and disorders, diabetes, diabetic complications, and hormonal diseases and disorders;.

Its status is currently believed to be active. Its class is unavailable. “GLYALA” is believed to be currently owned by “Teva Pharmaceuticals USA, Inc.”